Shares of Oracle (ORCL) Falling Amid $199.5M Payment to Settle False Claims Act Suit
Tweet
Share
E-mailGet Alerts ORCL Hot Sheet
Price: $142.07 -1.21%
Overall Analyst Rating:
SELL (= Flat)
Dividend Yield: 0.7%
EPS Growth %: +17.7%
Overall Analyst Rating:
SELL (= Flat)
Dividend Yield: 0.7%
EPS Growth %: +17.7%
Join SI Premium – FREE
Oracle (Nasdaq: ORCL) shares are being sold in Thursday's post-market session following news the tech giant will pay the US $199.5 million in order to resolve the suit related to the False Claims Act.
The stock last traded at $29.49, down almost 2 percent from the close.
The stock last traded at $29.49, down almost 2 percent from the close.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Oracle Health adds coding, dictation, and chart review to AI agent
- Scorpion Capital says short Twist Biosciences
- Citigroup set to join top banks in Anthropic IPO - Bloomberg
Create E-mail Alert Related Categories
Trader TalkSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
